BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$275.94 USD
+0.34 (0.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $275.92 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum D VGM
Earnings News For BIO
-
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
-
Bio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins Down
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad Laboratories (BIO) Surpasses Q4 Earnings Estimates
-
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
-
Bio-Rad Laboratories (BIO) to Post Q4 Earnings: What Awaits?
-
Bio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View
-
Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates
-
Bio-Rad: Q3 Earnings Snapshot
-
Bio-Rad: Q3 Earnings Snapshot
-
Bio-Rad Reports Third-Quarter 2023 Financial Results
-
Bio-Rad Laboratories (BIO) to Post Q3 Earnings: What Awaits?
-
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy?
-
Bio-Rad (BIO) Beats on Q2 Earnings Estimates, Cuts 2023 View
-
Bio-Rad Laboratories (BIO) Tops Q2 Earnings Estimates
-
Bio-Rad Reports Second-Quarter 2023 Financial Results
-
Bio-Rad Laboratories (BIO) to Post Q2 Earnings: What Awaits?
-
Bio-Rad (BIO) Q1 Earnings Beat Estimates, Operating Margin Down
-
Bio-Rad: Q1 Earnings Snapshot
-
Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates
-
Bio-Rad: Q1 Earnings Snapshot
-
Bio-Rad Reports First-Quarter 2023 Financial Results